CMS also has upcoming plans to impose fiscal penalties related to dialysis treatment.
Effective clinical trial design and ultimately drug approval require careful consideration of the endpoints selected.
Patient-centeredness should become a core component of clinical practice guidelines, according to Dr Kalantar-Zadeh.
Efforts should be directed at making nephrology more appealing to recruit more trainees.
Medicine is making progress to refine patient care.
Medical research inherently seeks to improve approaches to clinical care.
Recent studies have cast doubt on the universal superiority of the conventional approach to dialysis.
It is unclear to physicians why some patients develop calciphylaxis while others do not.
Randomized clinical trials are often considered the highest level on which medical care should be based.
As the rate of acceleration in ESRD incidence decline, physicians should expect heightened battles for the ESRD fountains.
Patients diagnosed with prostate cancer often struggle with their diagnosis.
Benjamin T Ristau, MD, and Robert G. Uzzo, MD, FACS, examine why adjuvant therapies have been so ineffective.
If ESRD patients face increasing difficulty getting a kidney transplant in coming years, they may see an artificial kidney as the next best alternative.
Advances in prostate cancer screening, management and therapeutics have vastly improved patient care.
No matter how much pharmacologic therapy advances, patient behavior will remain a significant factor in the outcomes achieved.
We may feel good treating a patient's edema, but is fluid retention always harmful?
Chronic diseases such as end-stage renal disease (ESRD) have now surpassed opportunistic infections as the leading cause of death among HIV-infected patients.
Physicians recognize the need for standards and process improvement in medicine. Case in point: Urinary Tract Infections.
For decades, prostate cancer risk (PCa) stratification was based primarily on the architectural pattern of the tumor.
Among the most important challenges in producing a medical newspaper is deciding what studies or topics on which to report.
Recently, increasing attention focused on mineralocorticoid receptor antagonists (MRAs) in treating chronic kidney disease (CKD).
Dr. Kalantar-Zadeh: Patients with Ebola deserve to be offered renal replacement therapy, even if odds of survival are slim.
Eisenhower warned Americans to beware of the "military-industrial complex" as it can overwhelm us.
The separation of continents no longer provides a secure buffer against the spread of communicable diseases from far-flung places.
We crave clinical and scientific data, yet we grieve the performance-based data increasingly directed toward us.
Many patients still insist that I need to check and manage their cholesterol.
For the first time, the federal CMS has made public a database showing what it pays out to individual physicians.
Human beings are unique in the animal kingdom when it comes to nutrition.
The term "personalized medicine" remains an overused promise to apply specific treatment plans.
This higher level of dialysis care in Canada is partly owed to substantially higher reimbursement fees for nephrologists.
When we move from one state to another, typically we must obtain a driver's license from the state to which we are relocating.
As a venue for presenting important research on kidney disease to the world, Kidney Week never disappoints.
After the end of 16-day federal shutdown in October, media headlines touted the financial impact on America and the cost of restarting the government.
Over the past 10 years the annual ESRD incidence rate per million U.S. population has remained stagnant or even shown sporadic downward trends.
For men at risk of developing prostate cancer (PCa), prophylactic prostatectomy seems almost irrational for several reasons
Once again, a study offers evidence that one of the keys to good nutrition is avoiding excess.
In the nephrology community, there have been heightened discussions and apparent enthusiasm about the revival of PD as the prototype for home dialysis.
The vow never to treat SRMs may seem hard to believe and self-defeating.
Two studies presented at the recent NKF Spring Clinical Meetings provide more evidence of a trend toward decreasing use of ESAs and decreasing hemoglobin levels.
Having just returned from the always-stimulating European Association of Urology annual congress, I'd like to share a few impressions.
Almost half a million Americans depend on chronic dialysis therapy to survive.
Physicians are more often defined by their ability to diagnose, treat, and research a disease than their willingness to manage its spectrum of risk.
How often have you met for business in a Starbucks, Coffee Bean, or any other coffee shop?
Kidney Week 2012, held in San Diego, is now history and as usual I like to reflect on the world's biggest and most prestigious meeting for kidney specialists.
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)